Cargando…
Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells
LB-100 is a novel PP2A inhibitor. Its activity in human colorectal cancer (CRC) cells was tested. The in vitro studies demonstrated that LB-100 inhibited survival and proliferation of both established CRC cells (HCT-116 and HT-29 lines) and primary human colon cancer cells. Further, LB-100 activated...
Autores principales: | Dai, Cuiping, Zhang, Xuning, Xie, Da, Tang, Peipei, Li, Chunmei, Zuo, Yi, Jiang, Baofei, Xue, Caiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707063/ https://www.ncbi.nlm.nih.gov/pubmed/29221169 http://dx.doi.org/10.18632/oncotarget.21336 |
Ejemplares similares
-
TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling
por: Zhao, Ting, et al.
Publicado: (2021) -
MicroRNA-145 Inhibits Cell Migration and Invasion in Colorectal Cancer by Targeting TWIST
por: Shen, Xuning, et al.
Publicado: (2019) -
Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
por: Yang, Ke, et al.
Publicado: (2023) -
LIM-Domain-Binding Protein 1 Mediates Cell Proliferation and Drug Resistance in Colorectal Cancer
por: Zhu, Mo, et al.
Publicado: (2022) -
Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma
por: Bi, Chongyao, et al.
Publicado: (2018)